missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

FLT4 (VEGFR3) Recombinant Human Protein DFS Item

FLT4 (VEGFR3) Recombinant Human Protein

Manufacturer:  Life Technologies LSPV4129

Catalog No. PV4129



Description

Description

FLT4 (VEGFR3), a receptor tyrosine kinase, is a key regulator of embryonic blood vessel development and adult angiogenesis. This kinase has been implicated in juvenile hemangioma, kaposi sarcoma, lymphangiomas, and hereditary lymphedemia.
Specifications

Specifications

NP_891555
Cell viability, proliferation and function, pharma and biopharma, protein assays and analysis, target and lead identification and validation
85.2kDa
75% by SDS-PAGE
–80°C
1 Each
FLT4 (VEGFR3), PCL
FLT4 (VEGFR3) was pre-diluted in enzyme dilution buffer and assayed in 25mM HEPES (pH 7.5), 10mM MgCl2, 1mM EGTA, 0.5mM Na3VO4, 5mM β-glycerophosphate, 2mM DTT, 0.01% Triton™ X-100, 200μM ATP, 200μg/mL poly [Glu, Tyr] 4:1 substrate and trace [32P]-γ-ATP for 10 minutes at 30°C
Kinase and inhibitors
VEGF receptors
FLT4 (VEGFR3) Recombinant Human Protein
Human
0.28mg/mL
10725, 2324
FLT4 (VEGFR3) Recombinant Human Protein
10μg
For research use only. Not for use in diagnostic procedures
Receptor tyrosine kinases
FLT4 (VEGFR3) Recombinant Human Protein
Kinase assay
Baculovirus
Amino acids 800-1297; Q890H, V1128L, H1146R
1,530nmoles of phosphate transferred to poly [Glu, Tyr] 4:1 substrate per minute per mg of total protein at 30°C. Activity determined at a final protein concentration of 2μg/mL
GST Tag
Documents

For Research Use Only. Not for use in diagnostic procedures.